Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agios Pharmaceuticals (AGIO) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Agios Pharmaceuticals (AGIO) over the last 14 years, with Q4 2025 value amounting to $12.4 million.

  • Agios Pharmaceuticals' Interest & Investment Income fell 3111.3% to $12.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $56.4 million, marking a year-over-year increase of 1725.35%. This contributed to the annual value of $56.4 million for FY2025, which is 1725.35% up from last year.
  • As of Q4 2025, Agios Pharmaceuticals' Interest & Investment Income stood at $12.4 million, which was down 3111.3% from $13.4 million recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Interest & Investment Income registered a high of $18.0 million during Q4 2024, and its lowest value of -$92000.0 during Q2 2021.
  • Moreover, its 5-year median value for Interest & Investment Income was $8.2 million (2023), whereas its average is $7.6 million.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Interest & Investment Income plummeted by 10520.07% in 2021, and later surged by 204891.3% in 2022.
  • Over the past 5 years, Agios Pharmaceuticals' Interest & Investment Income (Quarter) stood at $332000.0 in 2021, then skyrocketed by 1854.22% to $6.5 million in 2022, then soared by 32.92% to $8.6 million in 2023, then soared by 108.89% to $18.0 million in 2024, then crashed by 31.11% to $12.4 million in 2025.
  • Its Interest & Investment Income stands at $12.4 million for Q4 2025, versus $13.4 million for Q3 2025 and $14.5 million for Q2 2025.